Dose- and time-dependent α-synuclein aggregation induced by ferric iron in SK-N-SH cells

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · see citing works

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · see citing works

α-Synuclein Locus Triplication Causes Parkinson's Disease

Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383 · see citing works

AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836 · see citing works

The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737 · see citing works

The Haber–Weiss reaction and mechanisms of toxicity

Kehrer, J. P. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00231-6 · Cited by 1,418 · see citing works

Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains

Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383 · see citing works

The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316 · see citing works

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149 · see citing works

Dityrosine Cross-linking Promotes Formation of Stable α-Synuclein Polymers

Souza, J. M., Giasson, B. I., Chen, Q., Lee, V. M. ‐., & Ischiropoulos, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000206200 · Cited by 561 · see citing works

The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity

Golts, N., Petrucelli, L., Hardy, J., Lee, J. M., Farer, M., & Wolozin, B. L. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06048.2000 · Cited by 544 · see citing works

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis

Hirsch, E. C., Brandel, J. ‐., Galle, P., Javoy‐Agid, F., & Agid, Y. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08170.x · Cited by 537 · see citing works

Lewy bodies

Shults, C. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509567103 · Cited by 476 · see citing works

The pathogenesis of cell death in Parkinson's disease

Jenner, P. G., & Olanow, C. W. (2006) · Neurology · doi:10.1212/wnl.66.10_suppl_4.s24 · Cited by 449 · see citing works

Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study

Good, P. F., Olanow, C. W., & Perl, D. P. (1992) · Brain Research · doi:10.1016/0006-8993(92)91334-b · Cited by 427 · see citing works

Midbrain iron content in early Parkinson disease

Martin, W. R. W., Wieler, M., & Gee, M. (2008) · Neurology · doi:10.1212/01.wnl.0000286384.31050.b5 · Cited by 355 · see citing works

Formation and Removal of α-Synuclein Aggregates in Cells Exposed to Mitochondrial Inhibitors

Lee, H.-J., Shin, S. Y., Choi, C., Lee, Y. H., & Lee, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105326200 · Cited by 293 · see citing works

Individual dopaminergic neurons show raised iron levels in Parkinson disease

Oakley, A. E., Collingwood, J. F., Dobson, J., Love, G., Perrott, H. R., Edwardson, J. A., Elstner, M., & Morris, C. M. (2007) · Neurology · doi:10.1212/01.wnl.0000262033.01945.9a · Cited by 273 · see citing works

Single Particle Characterization of Iron-induced Pore-forming α-Synuclein Oligomers

Kostka, M., Högen, T., Danzer, K. M., Levin, J., Habeck, M., Wirth, A., Wagner, R., Glabe, C. G., Finger, S., Heinzelmann, U., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709634200 · Cited by 230 · see citing works

Magnesium Inhibits Spontaneous and Iron-induced Aggregation of α-Synuclein

Golts, N., Snyder, H. M., Frasier, M. A., Theisler, C. M., Choi, P., & Wolozin, B. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107866200 · Cited by 215 · see citing works

In vivo detection of iron and Neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage

Zecca, L., Berg, D., Arzberger, T., Ruprecht, P., Rausch, W. D., Musicco, M., Tampellini, D., Riederer, P., Gerlach, M., & Becker, G. (2005) · Movement Disorders · doi:10.1002/mds.20550 · Cited by 214 · see citing works

The 5′-untranslated region of Parkinson's disease α-synuclein messengerRNA contains a predicted iron responsive element

Friedlich, A. L., Tanzi, R. E., & Rogers, J. T. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001937 · Cited by 181 · see citing works

Increased Iron in the Substantia Nigra Compacta of the MPTP‐Lesioned Hemiparkinsonian African Green Monkey: Evidence from Proton Microprobe Elemental Microanalysis

Temlett, J. A., Landsberg, J. P., Watt, F., & Orime, G. W. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010134.x · Cited by 137 · see citing works

Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys

Mochizuki, H., Imai, H., Endo, K., Yokomizo, K., Murata, Y., Hattori, N., & Mizuno, Y. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90462-6 · Cited by 132 · see citing works

Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson’s disease

Halliday, G. M., Tredici, K. D., & Braak, H. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_16 · Cited by 113 · see citing works

Copper- and iron-induced differential fibril formation in α-synuclein: TEM study

..., B., Indi, S. S., & Rao, K. S. J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.06.052 · Cited by 110 · see citing works

Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in MES23.5 cells

Zhang, S., Wang, J., Song, N., Xie, J., & Jiang, H. F. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.025 · Cited by 104 · see citing works

Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6‐OHDA‐lesioned rats

Wang, J., Jiang, H. F., & Xie, J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05515.x · Cited by 95 · see citing works

Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload

Jiang, H., Luan, Z., Wang, J., & XIE, J. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.04.015 · Cited by 81 · see citing works

Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins

Wang, J., Xu, H., Yang, H., Du, X., Jiang, H. F., & Xie, J. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.10.003 · Cited by 79 · see citing works

Pathogenesis of Parkinson’s disease: oxidative stress, environmental impact factors and inflammatory processes

Yuan, H., Zheng, J., Liu, P., Zhang, S., Xu, J., & Li-min, B. (2007) · Neuroscience Bulletin · doi:10.1007/s12264-007-0018-x · Cited by 63 · see citing works

Increased iron in the substantia nigra of 6-OHDA induced parkinsonian rats: a nuclear microscopy study

He, Y., Thong, P. S. P., Lee, T., Leong, S. K., Shi, C., Wong, P. T. ‐., Yuan, S. Y., & Watt, F. (1996) · Brain Research · doi:10.1016/0006-8993(96)00313-7 · Cited by 61 · see citing works

Myricetin reduces 6-hydroxydopamine-induced dopamine neuron degeneration in rats

Ma, Z., Wang, J., Jiang, H. F., Liu, T., & Xie, J. (2007) · Neuroreport · doi:10.1097/wnr.0b013e32821c51fe · Cited by 49 · see citing works

Detection of DNA base-excision repair activity for oxidative lesions in adult rat brain mitochondria

Chen, D., Lan, J. Q., Pei, W., & Chen, J. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000715)61:2 · Cited by 47 · see citing works

[Increased DMT1 expression and iron content in MPTP-treated C57BL/6 mice].

Jiang, H. F., Qian, Z., & Xie, J. (2003) · PubMed · Cited by 40 · see citing works

Dopamine release rather than content in the caudate putamen is associated with behavioral changes in the iron rat model of parkinson’s disease

Junxia, X., Jiang, H. F., Wenfang, C., & Ming, Q. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00123-7 · Cited by 39 · see citing works

Time Dependent Effects of 6-OHDA Lesions on Iron Level and Neuronal Loss in Rat Nigrostriatal System

Wang, J., Jiang, H. F., & Xie, J. (2004) · Neurochemical Research · doi:10.1007/s11064-004-7031-5 · Cited by 36 · see citing works

Time course of dopaminergic cell death and changes in iron, ferritin and transferrin levels in the rat substantia nigra after 6-hydroxydopamine (6-OHDA) lesioning

He, Y., Lee, T., & Leong, S. K. (1999) · Free Radical Research · doi:10.1080/10715769900301611 · Cited by 30 · see citing works

The role of iron in brain ageing and neurodegenerative disorders

Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819 · see citing works

Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659 · see citing works

Iron Redox Chemistry and Implications in the Parkinson’s Disease Brain

Abeyawardhane, D. L., & Lucas, H. R. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4609702 · Cited by 35 · see citing works

Pay attention to resident training of anesthesiology

Bai, X. (2004) · Medical Information

Anesthesiology in the twenty-first century.Ideal way of female doctors in anesthesiology region in the twenty-first century.

Yokoyama, K. (1994) · THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA · doi:10.2199/jjsca.14.683

Discussion on cultivation of postgraduate of anesthesiology from TCM colleges

Xu, S.-Q., Zha, G.-F., & Zha, W.-X. (2011) · Zhonghua yixue jiaoyu tansuo zazhi · doi:10.3760/cma.j.issn.2095-1485.2011.06.013

PRINCIPLES OF ANESTHESIOLOGY

(1967) · doi:10.1097/00000441-196703000-00040 · Cited by 18 · see citing works

Changing Specialties

(1982) · doi:10.1213/00000539-198206000-00005 · Cited by 2 · see citing works